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Despite signiﬁcant contributions of monocytes to HIV persistence, the genomic basis of HIV-infection of
monocytes and its association with plasma viremia remain elusive. To understand HIV interactions
with monocytes during disease progression, monocytic transcriptomes from long-term non-progres-
sors (LTNP), HIVþ patients with viral load o1000, with viral load41000, and seronegative controls
were analyzed using Illumina microarray. Differentially expressed genes were identiﬁed (fold change
42; adjusted po0.05) and GSEA between HIVþ groups demonstrated that the down-regulation of the
pathways including Toll-like receptor (TLR) signaling, cytokine–cytokine receptor interaction, cell cycle
and apoptosis was signiﬁcantly associated with the viremic groups, whereas their up-regulation with
the LTNP group. The down-regulation of TLR pathway in the viremic patients was exempliﬁed by the
decreased expression of TLR with the subsequent tuning down of MAPK, NF-kB, JAK-STAT, and IRF
cascades. These data provide the ﬁrst transcriptomic distinction between HIVþ progressors and LTNPs
based on primary monocytes.
Crown Copyright & 2012 Published by Elsevier Inc. All rights reserved.Introduction
The phenotypic pliability and the differentiation ability of
monocytes empower this cell type to play a crucial role in HIV
pathogenesis through cellular differentiation, phagocytosis, and
antigen presentation. Compared to T cells and macrophages,
monocytes are much less permissive to HIV infection (Lewin
et al., 1998; McElrath et al., 1989) although all these cells express
HIV receptor CD4 and co-receptors CCR5 and/or CXCR4. In spite of
less than 1% of circulating monocytes directly infected in vivo,
infectious virus can be isolated from circulating monocytes in
untreated patients and HAART responders (Crowe and Sonza,
2000; McElrath et al., 1989), which could become a dominant012 Published by Elsevier Inc. All
.Q. Wu),
),
sydney.edu.au (B. Wang),source of plasma virus in HAART responders in whom HIV
replication in activated T cells is blocked (Zhu, 2002). In addition,
monocytes represent an important cellular reservoir by harboring
and trafﬁcking HIV into various tissue compartments through
differentiating into tissue macrophages or dendritic cells, which
enable productive HIV replication (Fulcher et al., 2004; Zhu,
2002). Furthermore, undifferentiated monocytic precursor cells,
such as CD34þ progenitor cells, may be infected with HIV and
pass on the virus to progeny monocytes and keep on renewing the
viral pool in peripheral blood monocytes (Alexaki et al., 2008;
Alexaki and Wigdahl, 2008).
Despite the signiﬁcant contributions of monocytes to HIV
persistence, the genetic basis of underlying pathogenic mechan-
isms remains elusive. To better understand HIV pathogenesis at
the genomic level, genome-wide transcriptomic studies of mono-
cytes and monocyte-derived macrophages (MDM) infected by HIV
in vitro were carried out, which identiﬁed several key areas of
monocyte dysfunction including induced proinﬂammatory gene
expression (Giri et al., 2006), up-regulation of IFN/NF-kB-respon-
sive chemokines and cytokines (Izmailova et al., 2003), impaired
Toll-like receptor recognition of HIV replication (Brown et al.,
2008), up-regulation of cytoskeletal genes (Cicala et al., 2002),
and modulation of the cell cycle (Coberley et al., 2004). Althoughrights reserved.
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monocyte interactions, these data in vitro may only partially
reﬂect the picture in vivo.
To date, the transcriptomic studies of ex vivo derived mono-
cytes are limited and they majorly focused on particular aspects
of monocyte dysfunction. For example, in the aspect of cell
apoptosis, the anti-apoptosis gene signature in circulating mono-
cytes from viremic subjects has been identiﬁed (Giri et al., 2009).
Regarding the immune activation, a mixed phenotype of both
increased and decreased proinﬂammatory features of monocytes
from viremic patients has been shown (Pulliam et al., 2004; Tilton
et al., 2006). As to metabolic disorder, a novel candidate gene
NAMPT has been highlighted in a recent transcriptome analysis
based on the results from gene ontology enrichment which
conﬁrmed a range of previously described dysregulated processes
in monocytes (Van den Bergh et al., 2010). Yet none of these
studies have looked into the global dysregulations of the biologi-
cal pathways in monocytes in different disease statuses as we
previously did for T cell subsets from viremic patients and long-
term non-progressors (LTNPs) (Wu et al., 2008a, 2008b, 2011).
Therefore, this study analyzed genome-wide transcriptome of
primary peripheral blood monocytes from HIVþ progressors
and therapy naı¨ve non-progressors in parallel. We used Illumina
HumanHT-12 v3 Expression BeadChip to proﬁle the transcrip-
tome (448,000 transcripts) of ex vivo-derived monocytes from
HIVþ therapy-naive LTNPs, viremic patients with viral load
(VL)o1000 (the intermediate/INT group), and viremic patients
with VL41000 (the HVL group) to identify transcriptional fea-
tures related to HIV disease progression (different stages ofTable 1
Clinical proﬁles of study patients.
Patient Group Age Gender Viral load
(copies/ml)
CD4
(cells/ll)
CD8
(cells/ll)
RNA
integrity
number
INT1 INT 54 F 87 418 473 10
INT2 INT 52 M 787 286 916 9.8
INT3 INT 31 F 194 300 548 9.9
INT4 INT 49 M 177 674 1131 10
INT5 INT 33 M 169 100 861 10
HVL1 HVL 25 F 120,000 191 358 7.9
HVL2 HVL 61 M 191,000 55 1026 9.5
HVL3 HVL 39 F 102,000 433 984 9.8
HVL4 HVL 43 F 7,090 385 585 7.2
HVL5 HVL 52 F 2,980 41 2587 9.7
LTNP1 LTNP 59 M o40 630 579 10
LTNP2 LTNP 33 F 57 780 900 9.8
LTNP3 LTNP 79 M o40 920 900 9.8
LTNP4 LTNP 51 M o40 714 476 9.7
LTNP5 LTNP 59 M o40 600 1300 10
INT1–5: patients on HAART with plasma viral loado1000; HVL1–5: patients on
HAART with plasma viral load41000; INTs and HVLs were on HAART for452 weeks
and consecutively experienced virological failure; LTNP1–5: long-term non-progressors
with plasma viral load o40 copies of HIV RNA/ml (except for LTNP2).
Fig. 1. Clustering analysis of global gene expression proﬁles of monocytes. The distanc
represents for patients with high viral load, INT for patients with intermediate viral lodisease progression). Focusing on the global dysregulation of
genetic networks, our analysis at the gene set level has shown
that between the HIVþ groups, the down-regulation of the
interrelated pathways including Toll-like receptor (TLR) signaling,
cytokine–cytokine receptor interaction, cell cycle and apoptosis,
and transendothelial migration (TEM) was signiﬁcantly associated
with the more severe disease status, whereas the non-progres-
sion/less advanced disease status was signiﬁcantly associated
with the up-regulation of these pathways. In the viremic patients,
the perturbed genetic networks were particularly highlighted by
the newly identiﬁed G1/S arrest in cell cycle and the global
impairment of TLR signaling exempliﬁed by the decreased expres-
sion of TLR with the subsequent tuning down of MAPK, NF-kB,
JAK-STAT, and IRF signaling cascades in conjunction.Results
Cluster analysis and identiﬁcation of differentially expressed genes
Primary CD14þ monocyte-derived total cellular RNA from 15
HIVþ patients and 4 sero-negative controls (5 LTNP, 5 HVL, 5 INT,
and 4 CTR; Table 1) were hybridized to the Illumina HumanHT-12
v3 Expression BeadChip. The hierarchical clustering analysis
revealed that HVL and INT groups formed an independent cluster
away from the LTNP and CTR groups (Fig. 1). Within the cluster
formed by INT and HVL groups, the INTs formed a sub-cluster
together and the HVL3, HVL4/5, and HVL1/2 were related to the INT
sub-cluster with subsequently decreased similarity. This pattern
indicated that the INTs were homogenous to each other, but the
HVLs were relatively heterogeneous, hence subsequent analysis
treated INT and HVL groups independently rather than combining
them into one group. Pair-wise comparisons between the four
groups were carried out and differentially expressed genes (DEGs)
with adjusted po0.05 and fold change42 were identiﬁed for each
comparison. The number of DEGs is listed in Table 2 and the lists of
DEGs are provided in Additional File 1. The limited number of DEGs
detected in the comparisons of the LTNP group versus the CTR group
(4 DEGs) and the HVL group versus the INT group (2 DEGs) was
consistent with the observation that LTNP and CTR groups formed a
distinct cluster from INT and HVL groups.e on the X-axis represents the similarity relationships among samples. The label H
ad, L for LTNPs, and C for controls.
Table 2
Number of differentially expressed genes in pairwise comparisons (fold change42
and adjusted po0.05).
INT vs
CTR
HVL vs
CTR
LTNP vs
CTR
INT vs
LTNP
HVL vs
LTNP
INT vs
HVL
Up 228 114 3 178 26 1
Down 111 63 1 107 53 1
Total 339 177 4 285 79 2
Up: up-regulation; down: down-regulation; vs: versus.
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levels of the selected DEGs were measured by quantitative PCR
(qPCR; Table 3). The mRNA from monocytes of the same patients at
the same time point was used for validation. The fold changes for
each pair-wise comparison evaluated by qPCR were fully consistent
with the results obtained frommicroarray, conﬁrming the reliability
of our microarray data. As we aimed at identifying monocyte
dysfunction in relation to HIV disease progression, our subsequent
analysis focused on the comparisons between HIVþ groups in order
to deﬁne genomic traits of HIV-infected individuals who have been
on HAART for452 weeks and consecutively experienced viremia
(INT and HVL groups) as opposed to therapy naı¨ve patients (like
LTNPs) who control HIV naturally.
Enriched KEGG pathways derived from DEGs
The DEGs derived from the pair-wise comparisons between
three HIVþ groups was then used to identify enriched KEGG
pathways. In the comparisons of the INT versus the LTNP group
and the HVL versus the LTNP group, 42 and 10 pathways were
signiﬁcantly enriched, respectively (adjusted po0.05; Additional
ﬁle 2). The 42 enriched pathways derived from the comparison of
the INT group versus the LTNP group fell into ﬁve functional
categories highly relevant to monocyte dysfunction in HIV dis-
ease, including cell signaling, cell cycle and apoptosis, cytoskele-
ton and cell migration, phagocytosis, and metabolism (Additional
ﬁle 2). Out of the 10 enriched pathways in the HVL group (versus
LTNP), 8 overlapped with the enriched pathways in the INT group
(versus LTNP), which belonged to the functional categories of cell
signaling and cell migration. No enriched pathways were found
for the two DEGs identiﬁed between the HVL and INT groups.
Gene set enrichment analysis
Gene set enrichment analysis (GSEA) was ﬁrst performed to
compare our dataset with published DEG lists derived from
studies on monocyte/MDM transcriptomes modulated by HIV
since 2002 (Cicala et al., 2002; Coberley et al., 2004; Gekonge
et al., 2012; Giri et al., 2009; Tilton et al., 2006; Van den Bergh
et al., 2010; Vazquez et al., 2005; Wen et al., 2005; Woelk et al.,
2004). The 10 DEG lists from both in vitro and ex vivo studies
included gene sets involved in multiple biological functions as
well as those focusing on particular aspects such as cell cycle
(Table 4). GSEA showed that in our transcriptome dataset, allTable 3
qPCR conﬁrmation of differentially expressed genes.
Gene
symbol
Pathways involved Group
comparison 
Fo
by
TLR4 TLR signaling HVLvsLTNPPNTLsvTNI8RLT
IL1B
TLR signaling 
Cytokine- cytokine receptor interaction 
HVLvsLTNP
PNTLsvTNIB1LI
PNTLsvTNI8LI
PNTLsvLVH8LI
CXCR4 Cytokine- cytokine receptor interaction 
Leukocyte transendothelial migration 
INTvsLTNP 
RTCsvLVH4RCXC
CCNH Cell cycle INTvsLTNP 
GNAI2 Leukocyte transendothelial migration INTvsLTNP 
ACTN4 Leukocyte transendothelial migration 
 Regulation of actin cytoskeleton 
INTvsCTR 
RTCsvTNILAGTI
PFN1
Regulation of actin cytoskeleton 
INTvsLTNP 
RTCsvLVH1NFP
RTCsvTNI1LFC
Fold change by qPCR was obtained from the mean expressions of the
microarray. All values represent fold changes between expression leve
Minus sign indicates down-regulation in the ﬁrst group whereas positive
GAPDH was used as an internal control and the normalizer in qPCR.these gene lists were signiﬁcant (FDRo0.25/default cut-off) in at
least one of the four group comparisons (INT/HVL versus LTNP
and INT/HVL versus CTR; Table 4). Moreover, 8 out of the 10 lists
reached the highest signiﬁcance level (FDRo0.01) in at least two
of the four group comparisons, which highlighted the biological
functions of chemokine/cytokine and interferon stimulated genes,
cell cycle and apoptosis-related genes, cell signalling and TLR2
stimulated genes, and TNF and MAPK networks altered in HIVþ
monocytes/MDM.
After conﬁrming the consistency of our dataset with previous
studies, GSEA was further attempted using the canonical path-
ways including 639 gene sets. GSEA examined the entire tran-
scriptome data instead of discrete DEGs and detected modest
changes when the members of a gene set exhibit strong cross-
correlation (Subramanian et al., 2005), whereas the DEG derived
pathway analysis was limited by the discrete nature of the DEGs,
which resulted in the detection of genes contributing to the
enriched pathway to be sporadic.
In the comparison of the INT group versus the LTNP group, 2 and
75 pathways were up- and down-regulated in the INT group,
respectively (FDRo0.25/default cut-off; Additional ﬁle 3). In the
comparison of the HVL group versus the LTNP group, 2 and 102
pathways were up- and down-regulated in the HVL group, respec-
tively (FDRo0.25; Additional ﬁle 3). In both comparisons, 60 path-
ways down-regulated in the viremic groups were overlapping, which
can be grouped into four functional categories including cell signal-
ling, cell cycle and apoptosis, metabolism, and miscellaneous
(Table 5). Under the category of cell signalling, the TLR signalling
(both FDR¼0) and cytokine–cytokine receptor interaction pathways
(both FDR¼0.002) were the most signiﬁcantly down-regulated KEGG
pathways (Table 5; Additional ﬁle 3). To illustrate the GSEA output,
the enrichment plot and the heat map of the core enrichment genes
for the down-regulation of TLR signalling pathway in the INT group
(versus LTNPs) are shown as representatives in Fig. 2. In the category
of cell cycle and apoptosis, the cell cycle (FDR¼0.038) and apoptosis
pathways (FDR¼0.067) were the top-ranked KEGG pathways down-
regulated in the INT group (versus LTNPs; Table 5; Additional ﬁle 3).
The metabolism category was mainly represented by the down-
regulation of pathways associated with carbohydrate and amino acid
metabolism in the viremic groups. As the immune-related pathways,
such as cell signaling, cell cycle, and apoptosis, had the most direct
relevance to the immune dysfunction characterizing HIV disease and
this aspect has been under constant investigations, we therefore
chose to focus on the immune-related pathways in this study.ld change 
 qPCR 
Fold change by 
microarray 
-2.0 -2.0 
1.2-0.2-
-20.4 -21.3  
4.42-7.62-
3.7-8.4-
5.62-5.22-
-3.0 -4.2
9.7-4.5-
-2.0 -2.2
2.1 2.3
3.1 3.3
4.25.2
1.8 2.5
1.23.2
1.28.1
tested genes in each group including all the samples used in the
ls of the ﬁrst group versus expression levels of the second group.
sign indicates up-regulation in the ﬁrst group. Housekeeping gene
Table 4
GSEA of our dataset compared with published gene lists derived from monocyte/MDM transcriptomes modulated by HIV.
Gene set name Pathways/biological functions
DEGs involved in HIV infection/
disease progression
Study description Reference Gene
set
size
INTvs
LTNP
FDR
HVLvs
LTNP
FDR
INTvs
CTR
FDR
HVLvs
CTR
FDR
Cicala_cytokine _chemokine Chemokine and cytokine In vitro gp120-treated vs
mock-treated MDM
(Cicala
et al.,
2002)
34 0.000nnn 0.000nnn 0.000nnn 0.075n
Coberley_HIV_induced_repressed Cell cycle regulators, translation,
cell signaling, TNF, MAPK
In vitro HIV-infected vs
mock-treated MDM
(Coberley
et al.,
2004)
38 0.858 0.391 0.286 0.122n
Woelk_inteferon-stimuated Interferon stimulated genes, host
defense genes
In vitro HIV-infected vs
mock-treated MDM
(Woelk
et al.,
2004)
12 0.881 0.000nnn 0.000nnn 0.001nnn
Vazquez_HIV-induced _MDM Signal transduction, transcription,
cell cycle and apoptosis, adhesion
molecules and receptors,
chemokines and cytokines,
proteases and protease inhibitors,
metabolism
In vitro HIV-infected vs
mock-treated MDM
(Vazquez
et al.,
2005)
124 0.005nnn 0.000nnn 0.030nn 0.023nn
Wen_HIVvsMock_U937 Signaling components,
transcription factors, cytokines,
apoptotic and anti-apoptotic
factors, growth factors, anti-HIV
infection genes
In vitro HIV-infected vs
mock-infected U937 human
promonocytes
(Wen
et al.,
2005)
33 0.000nnn 0.005nnn 0.040nn 0.151n
TILTON_cytokineLevel _correlation Type I interferon responses, NF-
kB, mitogen-activated protein
kinase, Jun signaling pathways,
general immune activation,
immune down-regulation, protein
degradation, protein secretion,
and apoptosis
Ex vivo correlations between
changes in gene expression
values and changes in
monocyte cytokine levels in
HIVþ patients on and off
therapy
(Tilton
et al.,
2006)
1295 0.040nn 0.107n 0.067n 0.068n
Giri_apoptosis_stable-differential Apoptosis-related gene signatures,
TNF-a signaling, CD40L/CD40
signaling, MAPK signaling, p53
modulation
Ex vivo HIVþ patients vs
healthy controls
(Giri et al.,
2009)
36 0.003nnn 0.005nnn 0.301 0.270
Van_HIV_serostatus_associated _
validated
Apoptosis, cell cycle,
transcriptional regulation,
immune response, protein
trafﬁcking, lipid metabolism
Ex vivo HIVþ patients vs
healthy controls
(Van den
Bergh
et al.,
2010)
24 0.000nnn 0.000nnn 0.023nn 0.071n
Gekonge_overlap_control_stimulatedvs_
control_HIVvsControl
TLR2-agonist stimulated gene
signature TNF (NFkB), p53 and
MAPK networks
Ex vivo and in vitro HIVþ
patients vs healthy controls
stimulated vs non-
stimulated controls
(Gekonge
et al.,
2012)
62 0.000nnn 0.000nnn 0.032nn 0.048nn
Gekonge_HIVvscontrol ERK/MAPK, TNF/IL6 (NFkB) and
p53 gene networks, apoptosis-
related gene signatures
Ex vivo HIVþ patients vs
healthy controls
(Gekonge
et al.,
2012)
281 0.005nnn 0.001nnn 0.121n 0.155n
DEGs: differentially expressed genes; gene set size: number of genes in a particular gene set; FDR: false discovery rate; INT: the intermediate viral load (VLo1000) group;
HVL: the high viral load group (VL41000); CTR: the healthy control group; LTNP: long-term non-progressors; MDM: monocyte-derived macrophages; vs: versus.
n FDRo0.25 (default cut-off).
nn FDRo0.05(more stringent).
nnn FDRo0.01(most stringent).
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and 74 pathways were up- and down-regulated in the HVL group,
respectively (FDRo0.25; Additional ﬁle 3). While most of these
differential pathways belonged to the same functional categories as
described above, the unique down-regulation of leukocyte trans-
endothelial migration pathway (FDRo0.24) stood out with a panel
of pathways closely related to cytoskeleton and cell migration such
as CXCR4 pathway (FDR¼0.161), integrin mediated cell adhesion
pathway (FDR¼0.171), and HSA04810 regulation of actin cytoske-
leton pathway (FDR¼0.236), which together conﬁrmed the
migration-related dysfunction during HIV disease progression.Down-regulation of TLR signaling pathway in both viremic groups
versus LTNPs
The highly signiﬁcant down-regulation of TLR signaling path-
way in the INT/HVL group versus LTNPs (Table 5; Additional ﬁle 3)
was exempliﬁed by the decreased TLR expression with subse-
quent tuning down of MAPK, NF-kB, JAK-STAT, and IRF signaling
cascades in conjunction. For a detailed inspection of this pathway,the results from the comparison of the INT group versus the LTNP
group were used as a representative (Fig. 3). Along the MAPK
branch in TLR pathway, the core enrichment genes (Table 6)
included three levels of kinase (MAP3K8/Tpl2, MAP2K3/MKK3,
and MAPK3/ERK), the MAPK induced transcription factor JUN
from AP-1 family, and the inﬂammatory genes TNF-a, IL6, and IL-
1b induced by JUN/AP-1 proteins. Along the JAK-STAT arm of TLR
pathway, the core enrichment genes included the type I IFN-b,
transcription factor STAT1, chemokines CXCL10/IP-10 and CXCL9/
MIG, both induced by STAT1. The other two arms in the TLR
pathway involved the activities of NF-kB/Rel proteins and inter-
feron regulator factors (IRFs). As shown in Fig. 3, both arms
activated multiple inﬂammatory genes and IRF7 in particular
drove type I interferon production.Down-regulation of cytokine network in both viremic groups
versus LTNPs
Cytokine–cytokine receptor interaction (HSA04060) was one of
the most signiﬁcantly down-regulated pathways in both INT and
Table 5
Top ﬁve enriched pathways in each functional category derived from GSEA between INT/HVL and LTNP groups.
Pathways down-regulated in the comparisons of both INT versus LTNP and HVL versus LTNP
Gene set name Gene set size INTvsLTNP NOM p-val INTvsLTNP FDR HVLvsLTNP NOM p-val HVLvsLTNP FDR
Cell signaling
HSA04620_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY 102 0.000 0.000 0.000 0.000
HSA04060_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION 253 0.000 0.002 0.000 0.002
CYTOKINEPATHWAY 20 0.000 0.003 0.000 0.006
ERYTHPATHWAY 15 0.000 0.003 0.000 0.002
IL1RPATHWAY 32 0.002 0.011 0.000 0.000
Cell cycle and apoptosis
HSA04110_CELL_CYCLE 113 0.000 0.038 0.042 0.222
G1_TO_S_CELL_CYCLE_REACTOME 66 0.006 0.065 0.016 0.112
HSA04210_APOPTOSIS 83 0.002 0.067 0.005 0.114
VIPPATHWAY 27 0.004 0.058 0.002 0.007
APOPTOSIS 66 0.006 0.068 0.063 0.205
Metabolism
BETA_ALANINE_METABOLISM 26 0.002 0.059 0.006 0.049
PROPANOATE_METABOLISM 30 0.011 0.067 0.009 0.047
HSA00640_PROPANOATE_METABOLISM 34 0.021 0.069 0.021 0.115
HSA00252_ALANINE_AND_ASPARTATE_METABOLISM 33 0.013 0.101 0.043 0.147
PROSTAGLANDIN_SYNTHESIS_REGULATION 28 0.025 0.106 0.042 0.147
Misc
HYPERTROPHY_MODEL 16 0 0.003 0.000 0.008
BREAST_CANCER_ESTROGEN_SIGNALING 93 0 0.026 0.000 0.002
SMOOTH_MUSCLE_CONTRACTION 139 0 0.028 0.000 0.006
HSA05222_SMALL_CELL_LUNG_CANCER 87 0.002 0.037 0.002 0.068
HSA04640_HEMATOPOIETIC_CELL_LINEAGE 87 0.002 0.099 0.000 0.000
Up-regulated pathways in the viremic groups versus LTNPs
COMPPATHWAY 16 NA NA 0.002 0.051
HSA04950_MATURITY_ONSET_DIABETES_OF_THE_YOUNG 21 NA NA 0.000 0.078
HSA03010_RIBOSOME 85 0 0.019 NA NA
HSA00010_GLYCOLYSIS_AND_GLUCONEOGENESIS 64 0 0.154 NA NA
Gene set size: number of genes in a particular gene set; NOM p-val: nominal p-value; FDR: false discovery rate Up: up-regulated; Dn: down-regulated;NA: not applicable.
Fig. 2. Enrichment plot and heat map for the gene set of Toll-like receptor signaling pathway by GSEA. A. Enrichment plot for monocytes from the INT group (INT versus
LTNP). Bottom, plot of the ranked list of all genes. Y-axis, value of the ranking metric; X-axis, the rank for all genes. Genes whose expression levels are most closely
associated with the INT or LTNP group get the highest metric scores with positive or negative sign, and are located at the left or right edge of the list. Middle, the location of
genes from the Toll-like receptor pathway within the ranked list. Top, the running enrichment score for the gene set as the analysis walks along the ranked list. The score at
the peak of the plot is the enrichment score (ES) for this gene set and those genes appear before or at the peak are deﬁned as core enrichment genes for this gene set. B.
Heat map of the core enrichment genes corresponding to A. The genes that contribute most to the ES, i.e., genes that appear in the ranked list before or at the peak point of
ES, are deﬁned as core enrichment genes and highlighted by the red rectangle. Rows, genes; columns, samples. Range of colors (red to blue) shows the range of expression
values (high to low).
J.Q. Wu et al. / Virology 435 (2013) 308–319312HVL groups when they were compared to the LTNPs (both
FDR¼0.002; Table 5 and Additional ﬁle 3). Taking the comparison
between the INT group and the LTNP group as the representative(Fig. 4), the inspection of the core enrichment genes of this pathway
revealed a wide range of down-regulation of genes encoding
cytokine receptors and their ligands (Table 6), which can be
Fig. 3. Coordinately down-regulated genes of Toll-like receptor signaling pathway in monocytes from the INT group (INT versus LTNP). The pathway ﬁgure is adapted from
Kyoto Encyclopedia of Genes and Genomes (KEGG; http://www.genome.jp/kegg/). The proteins encoded by the coordinately down-regulated genes in the INT group are
highlighted in red. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 6
Core enrichment genes contributing to the enrichment of the pathways highly relevant to monocyte dysfunction during HIV disease progression.
Pathway name Figure Comparison FDR Core enrichment genes contributing to the pathway enrichment
HSA04620_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY Fig. 3 INTvsLTNP 0.000 CCL4, CHUK, CXCL9, NFKBIA, TLR6, PIK3R1, PIK3CB, TICAM2, MAPK3,
TLR5, PIK3CD, TLR2, PIK3R2, IRF5, STAT1, NFKB1, MAP2K3, IRF7,
IKBKG, IFNB1, IKBKB, TLR7, TLR8, TICAM1, TLR4, JUN, TNF, IL8, CXCL10,
IL6, MAP3K8, CCL5, CCL3, IL1B
HSA04060_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION Fig. 4 INTvsLTNP 0.002 CXCL6, CXCL9, TNFRSF10B, LTA, CCL7, ACVR1, CCL23, IFNGR2,
TNFRSF14, IL2RB, CCR1, CX3CR1, CSF1R, TNFSF14, IL15, TNFSF10, LTB,
IFNGR1, CXCL1, IFNB1, CCL2, IL7R, IL12RB1, CCL8, IL23A, TNFRSF21,
IL11RA, VEGFA, CXCL16, TNF, IL8, CXCL10, IL6, IL1A, CXCR4, CCL20,
CCL5, OSM, CCL3, CXCL2, IL1B
HSA04110_CELL_CYCLE Fig. 5 INTvsLTNP 0.038 RBX1, SKP2, MCM4, CDK2, YWHAH, ORC5L, PTTG2, ANAPC7, HDAC2,
GADD45G, CREBBP, E2F2, CDC2, HDAC1, MCM3, CDC26, CDC14A,
CHEK2, PCNA, CUL1, PTTG1, ORC2L, TFDP1, YWHAB, CDKN1B, SMAD3,
ATM, CDC23, PRKDC, GADD45A, RB1, SMAD4, ANAPC10, MCM7,
ANAPC4, MCM6, YWHAG, RBL2, CDC16, BUB3, CCND2, GADD45B,
CCNH, CDKN1A
HSA04210_APOPTOSIS Additional
ﬁle 4
INTvsLTNP 0.067 CHUK, CYCS, NFKBIA, TNFRSF10B, CASP7, CFLAR, PIK3R1, PIK3CB,
AIFM1, ATM, PIK3CD, PIK3R2, PRKAR1A, TNFSF10, NFKB1, IRAK3,
APAF1, BIRC2, IKBKG, IKBKB, IRAK2, TNF, IL1A, IL1B
HSA04670_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION Additional
ﬁle 5
HVLvsINT 0.240 VASP, CLDN14, PECAM1, PIK3CB, PRKCA, CYBA, RASSF5, ITGA4, PXN,
ITGAL, RAC2, GNAI2, ITGAM, CD99, MAPK14, NCF4, PIK3CG, ACTN4,
NCF1, CXCR4, MMP9
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structure of the receptors and the signal transduction cascades.
Group 1 was associated with G protein-coupled receptors,
which included eight genes from CXC subfamily encoding CXCL1,
CXCL2, CXCL6, IL8, CXCL9, CXCL10, CXCL16, and HIV co-receptor
CXCR4, CX3CR1 from CX3C subfamily, and eight genes from CC
subfamily encoding CCL20, CCL2 (monocyte chemotactic protein-
1; MCP-1), CCL3 (macrophage inﬂammatory protein-1a; MIP-1a),
CCL7, CCL5, CCR1, CCL23, and CCL8 (Fig. 4).
Group 2 was related to cytokine receptors connected to Janus
kinase (JAK) family of tyrosine kinases. Based on the conserved
motifs in their extracellular amino acid domain, they can be
further divided into ﬁve subgroups: (1) gp130 subunit shared
(IL11RA, IL6, and oncostatin M); (2) IL2 receptor g chain shared
(IL2RB, IL7R, and IL15); (3) IL12 receptor subunit beta-1 shared
(IL12RB1 and IL23A); (4) platelet-derived growth factor (PDGF)family CSF1R and VEGFA; and (5) interferon family IFNB1,
IFNGR1, and IFNGR2 (Fig. 4).
Group 3 involved TNF receptors including genes encoding recep-
tors TNFRSF10B, TNFRSF21, and TNFRSF14 and genes encoding
cytokines TNFSF10, TNF, LTA, LTB, and TNFSF14 (Fig. 4). Group
4 comprised of IL1 family genes which included IL1A and IL1B. In
group 5, the genes belonged to TGF-b family, which was repre-
sented by ACVR1 receptor.Down-regulation of cell cycle and apoptosis pathways in both viremic
groups versus LTNPs
In addition to cell signaling dysfunction, the cell cycle pathway
(HSA04110) was also signiﬁcantly down-regulated in the viremic
groups (FDR¼0.038 for INT versus LTNP; FDR¼0.222 for HVL
versus LTNP; Table 5 and Additional ﬁle 3). As the results from the
Fig. 4. Coordinately down-regulated genes of cytokine–cytokine receptor interaction pathway in monocytes from the INT group (INT versus LTNP). The pathway ﬁgure is
adapted from Kyoto Encyclopedia of Genes and Genomes (KEGG; http://www.genome.jp/kegg/). The proteins encoded by the coordinately down-regulated genes in the
INT group are highlighted in red. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. Coordinately down-regulated genes of cell cycle pathway in monocytes from the INT group (INT versus LTNP). The pathway ﬁgure is adapted from Kyoto
Encyclopedia of Genes and Genomes (KEGG; http://www.genome.jp/kegg/). The proteins encoded by the coordinately down-regulated genes in the INT group are
highlighted in red. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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it was used as the representative for further inspection. Forty-
four out of one hundred and thirteen gene members were
core enrichment genes (Table 6) and the coordinated down-
regulation of these genes appeared in all phases of cell cycle
including G1 to S, G2 to M, and metaphase to anaphase transition
(Fig. 5).Down-regulated genes encoding for proteins directly pro-
moted G1 to S transition included (1) CCND2 encoding for cyclin
D and cyclin dependent kinase 2 (CDK2); (2) transcription factors
E2F2 and TFDP1encoding DP1; (3) DNA biosynthesis complex ORC
(origin recognition complex; gene ORC2 and ORC5) and mini-
chromosome maintenance (MCM) complex (gene MCM3, 4, 6, 7).
While genes inhibiting the transition were also down-regulated
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protein 2 (SKP2), CDKN1B encoding KIP1, and CDKN1A encoding
CIP1, they most likely represent the coordinated change as the
down-regulation of the core enrichment genes directly involved
in the transition promotion clearly implicated G1/S arrest.
In the G2 to M transition, the down-regulation of CDC2/CDK1
was observed, which form complexes with cyclin A and B, leading
to cell cycle progression. Genes encoding proteins that promote
the activity of CDK1 complexes including CDC25A, B, and C,
were not signiﬁcantly altered, which together with CDC2 down-
regulation may implicate G2/M arrest. Additionally, genes
involved in DNA damage checkpoint were coordinately down-
regulated in the INT group such as DNA-PK (gene PRKDC) and
ATM. Three genes ANAPC4, ANAPC7, and ANAPC10 encoding for
anaphase promoting complex (APC), which triggers the meta-
phase to anaphase transition, were also signiﬁcantly down-
regulated in the INT group. Closely associated with the cell cycle
was the apoptosis pathway (HSA04210), which was signiﬁcantly
down-regulated in the viremic groups (FDR¼0.067 for INT versus
LTNP; FDR¼0.114 for HVL versus LTNP; Additional ﬁle 3). Further
inspection of the apoptosis pathway in INT versus LTNP compar-
ison revealed that 24/83 genes were core enrichment genes
(Table 6; Additional ﬁle 4).
Down-regulation of transendothelial migration pathway in the HVL
group versus the INT group
In the list of differentially regulated pathways between the HVL
and INT groups, the leukocyte transendothelial migration pathway
(HSA04670) was uniquely down-regulated in the HVL group
(FDR¼0.24; Additional ﬁles 3 and 5). Inspection of the migration
pathway revealed that 21/113 genes were core enrichment genes
(Table 6), which included genes encoding for the following proteins:
(1) chemokine receptor CXCR4 coupled to G protein GI/GNAI2,
which activates through PI3K (PIK3CB and PIK3CG) and RAC2,
eventually impacts cell motility; (2) integrins involved in cellular
adhesion (ITGA4, ITGAL, and ITGAM) and RAPL/RASSF5 involved in
enhanced adhesion of integrin complexes to ICAM1; (3) microﬁla-
ment protein a-actinin (ACTN4) and vasodilator-stimulated phos-
phoprotein (VASP) involved in actin-based mobility; and (4) cell
adhesion molecule PECAM1, a component of tight junction strands
claudin 14 (CLDN14/CAMs), cell surface glycoprotein CD99, and
matrix metallopeptidase 9 (MMP9) involved in extracellular matrix
degradation. Along the passage of ICAM1-mediated signals was the
coordinated down-regulation of PKC encoded by PRKCA required for
ICAM1 dependent leukocyte migration and paxillin encoded by PXN
involved in actin-membrane attachment at sites of focal adhesion.
Along the VCAM1-mediated signal passage was the coordinated
down-regulation of PI3K encoded by PIK3CB and PIK3CG, 3 subunits
of NADPH oxidase (p22phox, p47phox, and p40phox encoded by
CYBA, NCF1, and NCF4, respectively), MMPs encoded by MMP9, and
P38 encoded by MAPK14.Discussion
Our study provides the ﬁrst comprehensive and panoramic snap-
shot into the monocytic transcriptome by investigating the global
dysregulations of the biological pathways in circulating primary
monocyte transcriptomes derived from HIV healthy donors, HIVþ
progressors, and long-term non-progressors (Table 1). The main
objective of the study was to identify genomic signatures associated
with both progressive and non-progressive HIV disease. The compar-
ison between our dataset and previous microarray studies on mono-
cyte/MDM transcriptomes (Cicala et al., 2002; Coberley et al., 2004;
Gekonge et al., 2012; Giri et al., 2009; Tilton et al., 2006; Van den
Bergh et al., 2010; Vazquez et al., 2005; Wen et al., 2005; Woelk et al.,2004) using GSEA revealed that the extracted 10 gene lists were all
signiﬁcant (FDRo0.25) in at least one of the four group comparisons
(INT/HVL versus LTNP and INT/HVL versus CTR; Table 4) and eight
lists were highly signiﬁcant (FDRo0.01) in at least two group
comparisons, which unambiguously conﬁrmed the reliability of our
data. While in accordance with published gene lists in the context of
monocyte-HIV interactions, our data provided a better genome-wide
coverage of monocyte transcriptome (448,000 gene transcripts)
than the previous studies. As expected, the enriched pathways
derived from the DEGs were broadly consistent with the enriched
pathways detected by GSEA using canonical pathways (Additional
ﬁles 2 and 3). In addition, GSEA enabled a more comprehensive
detection of genes contributing to the enrichment of the pathways
correlated with disease progression, as it considered all of the genes
in the experiment, not only those above the cut-off of fold change or
signiﬁcance (Subramanian et al., 2005). Therefore, the subsequent
discussion focused on the pathways signiﬁcantly associated with
progressive phase of HIV disease revealed by GSEA. Since the
immune-related pathways had the most direct relevance to the
immune dysfunction characterizing HIV disease and this aspect has
been under constant investigations, our discussion centered on the
immune-related pathways top-ranked by GSEA, which included
pathways of TLR signaling, cytokine–cytokine receptor interaction,
cell cycle and apoptosis, and endothelial migration.
At the transcriptomic level, the overall down-regulation of the
TLR signaling pathway in the viremic groups (versus LTNP; Fig. 3;
Table 6) manifested by the decreased TLR expression with sub-
sequent tuning down of the expression of the genes encoding for
MAPK, NF-kB, JAK-STAT, IRF signaling cascades, and the reduced
expression of cytokine genes reﬂected the deﬁciencies of innate
immune response in monocytes from viremic patients. To our
knowledge, this study is the ﬁrst to report the simultaneous
tuning down of the genes encoding for all the four signaling
cascades integrated within the TLR pathway during HIV disease
progression, though previous studies have implicated the dys-
function of the individual signaling arm discretely. TLRs represent
an important category of pathogen recognition receptors, which
are crucial in the ﬁrst-line defense against foreign microbes and
are also important for modulating the adaptive immune response.
The possible link between HIV infection and TLR expression was
suggested by the ﬁnding that the TLR2 expression on monocytes
from HIV patients was modulated when compared to the healthy
controls (Heggelund et al., 2004b). Moreover, it has been sug-
gested that the altered TLR expression and a deﬁcient TLR2/4
signaling through ERK may cause the decreased production of
TNF-a in alveolar macrophages, which was associated with HIV
disease progression (Nicol et al., 2008). In our study the detection
of the down-regulation of the enrichment genes along the MAPK
branch not only fully supported the previous observations on
altered expressions of TLR2/4, ERK/MAPK3, and TNF-a, but also
extended the previous postulation to a clear view of the perturbed
MAPK signaling cascade integrated within the TLR pathway
during disease progression, which revealed the comprehensive
link underlying the observed discrete changes in gene expression.
Similarly, the attenuation of the expression of genes along the
NF-kB branch detected in our study ex vivo conﬁrmed and
extended the previous study reporting the diminished IkBa
degradation and NF-kB RelA nuclear translocation through TLR4
in MDM infected by HIV in vitro (Noursadeghi et al., 2009).
Additionally, the reduced expression of the genes along the
JAK-STAT arm associated with the HIV disease progression
accorded well with the previous ﬁnding of loss of IFNa/b respon-
siveness in monocytes manifested by the decreased IFNa/bR
expression, IFNa-induced STAT1 phosphorylation, and IFNa
induced gene expression, which correlated signiﬁcantly with
HIV disease progression markers (Hardy et al., 2009).
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the TLR pathway is of particular interest as it incorporates two
endosomal receptors TLR7/8, which recognize single stranded viral
RNA such as HIV. In line with this ﬁnding, a previous study has
reported that the expression of TLR7/8 and TNF-a secretion
was signiﬁcantly decreased in monocytes from chronic and AIDS
subjects compared to LTNPs (Nian et al., 2012). Furthermore, TNF-a
secretion was decreased signiﬁcantly at each subsequent HIV
infection stage via TLR7/8 triggering. While both studies high-
lighted the down-regulation of TLR7/8 and inﬂammatory cytokine
genes during disease progression (Fig. 3), ours also pinned down
the potential link between the reduced expression of TLRs and the
cytokine genes to the MyD88-dependent passage (TLR-MyD88-
IRAK-TRAF6-MAPK/NFkB) in the TLR pathway. Since previous
ﬁndings of the persistent TNF production in T cells and PBMCs
from HIVþ patients implicated the increased HIV-related inﬂam-
mation effects such as cell apoptosis (Aukrust et al., 1999; Ledru
et al., 2000), the down-regulation of TLR7/8 and inﬂammatory
cytokine genes in monocytes observed here may thus suggest the
tuning down of inﬂammation status during disease progression,
which could contribute to monocyte survival as a viral reservoir.
Given the fact that only a very low frequency of monocytes are
directly infected by HIV, the global down-regulation of the TLR
pathway is likely to arise from the secondary effects of the overall
process of immunopathogenesis in vivo such as perturbed cytokine
network, or the activity of the virus components, which do not
require direct infection such as HIV envelope glycoprotein gp120.
The decreased expression of cytokine genes observed in the
TLR signaling pathway was further manifested by the down-
regulation of the cytokine–cytokine receptor interaction pathway
in the viremic groups (versus LTNP; Fig. 4). One of the most
pronounced changes in this pathway was the signiﬁcant and
systematic down-regulation of genes encoding proinﬂammatory
cytokines including IL-1b, IL-6, IL-8, TNF-a and the receptor
CSF1R in the viremic groups (Table 6). On the other hand, the
anti-inﬂammatory cytokine genes such as TGF-b, IL-4, L-10, and
IL-13 did not show any signiﬁcant changes between the INT/HVL
and the LTNP groups. This selective reduction in the expression
of proinﬂammatory cytokine genes during disease progression
was consistent with the previous report that the frequencies of
monocytes producing proinﬂammatory cytokines (IL1b, IL-6, and
TNFa) was diminished in patients with viremia during the time
off therapy compared to the time on therapy with effective
control of viral replication (Tilton et al., 2006). The reduction in
the expression of proinﬂammatory cytokine genes through
the TLR pathway could again implicate the tuning down of the
inﬂammatory effects of monocytes as the increased levels of b
chemokines were suggested to drive the inﬂammatory loop
leading to cell apoptosis in PBMC from the HIVþ patients
(Heggelund et al., 2004a). On the other hand, another study
showed an invasive phenotype of primary monocyte character-
ized by signiﬁcant increase in expressing CD16, CCR5, and MCP-1
associated with disease severity (Pulliam et al., 2004). This
increase was mixed with unchanged expression of proinﬂamma-
tory cytokine genes IL-1, IL-6, and TNF-a, whereas our data
showed concordantly reduced expression of both chemotaxis
and proinﬂammatory genes. The contradiction may come from
the different deﬁnitions of high plasma VL, as the previous study
deﬁned VL410,000 (Pulliam et al., 2004) and our study used
VL41000 as the threshold.
Despite the aforementioned contradiction, our observation of
the decreased expression of chemokine genes in the viremic
groups was fully supported by the recent monocytic transcrip-
tome analysis which identiﬁed 6 signiﬁcantly down-regulated
genes involved in chemotaxis in the viremic patients (Van den
Bergh et al., 2010). Coincidently, 4 out of these 6 genes (CCL23,CX3CR1, CXCL2, and IL8) overlapped with our core enrichment
genes in the cytokine pathway. Among the 7 CC chemokine genes
we identiﬁed to be down-regulated, RANTES/CCL5 and MIP-1a/
CCL3 were well known to suppress HIV replication in both CD8þ
T cells and PBMCs from infected individuals (Cocchi et al., 1995;
Vicenzi et al., 2000). Thus, the down-regulation of these two
chemokine genes may indicate the impaired immune responses
of monocytes during the disease progression. The impaired
immune responses of monocytes in the viremic groups were
further demonstrated by the decreased expression of the recep-
tors for type I cytokine genes involved in the stimulation of cell-
mediated immunity (IFNGR1, IFNGR2, and IL2RB). Interestingly,
the core enrichment gene IL-15, which shared many activities
with IL-2 and was down-regulated in viremic patients here, was
also found to be expressed at signiﬁcantly higher levels in the
monocytes of LTNPs than in those of HIV progressors (Tarkowski
et al., 2011).
The overall down-regulation of the expression of the genes
encoding for cell cycle pathway suggested both G1/S and G2/M
arrest in monocytes from viremic patients (versus LTNP; Fig. 5;
Table 6). While the G2/M arrest was consistent with the ﬁnding
in MDM treated with HIV strains (Coberley et al., 2004), the G1/S
transitioning was not so well replicated in the study by Coberley
et al. as only four genes were detected to be uniquely expressed
in virus-treated cultures. In contrast, our dataset indicated G1/S
arrest evidenced by the down-regulation of genes encoding
cyclin D and CDK2 pivotal for S-phase entry, and reduced
expression of transcription factors (E2F2 and TFDP1), DNA
biosynthesis complexes ORC, and MCM complex. This contra-
diction may arise from the differences between cell cultures
in vitro in other studies and monocytes isolated ex vivo in our
study. Closely associated with the dysregulation of the cell cycle
was the down-regulation of the expression of the genes encod-
ing for cell apoptosis pathway (Table 6; Additional ﬁle 4), which
contributed to monocytes survival as a viral reservoir. This area
of dysfunction has been investigated both ex vivo and in vitro by
previous studies, which identiﬁed the anti-apoptosis gene sig-
nature in monocytes from HIVþ subjects and detected the
reduced sensitivity of infected monocytic cell lines compared
with their uninfected counterpart, respectively (Giri et al., 2009;
Pinti et al., 2003).
In the comparison of the HVL group versus the INT group, the
genes encoding for leukocyte TEM pathway was uniquely down-
regulated in the HVL group (Table 6; Additional ﬁle 5), which
implicated the altered immunosurveillance capacity in mono-
cytes during HIV disease progression. Consistently, the previous
study showed that monocyte TEM was diminished in the stage B/
C patients, but unimpaired in stage A patients (Trial et al., 1995).
The TEM dysfunction was also detected in MDM infected by HIV
in vitro, which caused a defect in reverse TEM without affecting
forward TEM (Westhorpe et al., 2009).
It should be noted here that this study uses a cross-sectional
design, which cannot provide dynamic ﬁndings from a longitudinal
perspective such as the evaluations of the normalization of TLR
expression upon treatment by the repeated measures of the same
individuals upon therapy intervention and the identiﬁcation of the
associations between altered gene expression and viral replication/
immunosuppression by the consecutive viremia data. The lack of
the prospective transcriptome data also limits further assessment
of the stability of the gene signatures associated with disease
progression. Future studies could further conﬁrm the gene signa-
tures identiﬁed here from both retrospective and prospective
views. In addition, this is a transcriptomic study which provides
changes only at mRNA level and functional studies at the protein
level in future would help to conﬁrm the changes reported here
and transform them into a mechanistic overview.
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Patient proﬁles and collection protocol
Five HIV-infected LTNPs, ﬁve HIVþ patients on HAART with
VLo1000 (INT) and ﬁve with VL41000 (HVL) along with four
healthy HIV seronegative controls (CTR) were studied. The infec-
tion time for LTNP1, LTNP3, LTNP4, and LTNP5 are 420 years, and
L2414 years. These treatment-naı¨ve LTNPs have maintained high
CD4þ T cell counts (4500 cells/ml) and below detectable plasma
viremia (o40 HIV RNA copies/ml plasma; Table 1) except LTNP2
with very low plasma viremia (57 HIV RNA copies/ml plasma).
Patients in the INT and HVL groups were on HAART for452
weeks and consecutively experienced virological failure. The INT
and HVL groups had VL less and more than 1000, respectively and
they all had CD4þ T cell counts o500 cells/ml except for INT4.
These patients received two NRTIs (zidovudine, lamivudine,
stavudine, emtricitabine, tenofovir) in association with one or
two protease inhibitors (darunavir, ritonavir, indinavir, saquina-
vir, atazanavir). Twelve patients came from the HIV clinic at
Westmead Hospital and three patients plus the four healthy
controls came from the Australian Red Cross Blood Service in
Sydney. This study was approved by the Sydney West Area Health
Services Research Ethics Committee, and all blood samples were
collected after individual informed written consent.
Puriﬁcation of CD14þ monocytes and RNA isolation
A single blood sample (10–20 ml in EDTA) was obtained from
each patient. After separation of plasma, primary PBMC were
isolated immediately after obtaining blood samples by Ficoll-
gradient centrifugation and puriﬁed. This aspect was strictly
followed in our experiments because of previously described lower
RNA yields and possible changes in gene expression proﬁles upon
storage of blood (Lyons et al., 2007). CD14þ monocytes were then
obtained by positive isolation with antibody-conjugated magnetic
beads according to the manufacturer’s instructions (Miltenyi
Biotech, Germany) with a purity498.6% as veriﬁed by ﬂow
cytometry. Binding of antibody to CD14 does not trigger signal
transduction and a previous study has clearly demonstrated that
CD14 positive selection does not alter cellular transcriptome by
comparing gene expression proﬁles in parallel using either positive
or negative selection (Lyons et al., 2007). Total RNA was isolated
from puriﬁed cells using RNeasy Mini kit (Qiagen Pty Ltd., Clifton
Hill, Victoria, Australia) with an integrated step of on-column
DNase treatment.
cRNA preparation, microarray hybridization and scanning
RNA quality was checked by Agilent Bioanalyzer and RNA
Integrity Scores are higher than 7 for all the samples. cRNA
ampliﬁcation and labeling with biotin were performed using
Illumina TotalPrep RNA ampliﬁcation kit (Ambion, Inc., Austin,
USA) with 250 ng total RNA as input material. cRNA yields were
quantiﬁed with Agilent Bioanalyzer and 750 ng cRNAs were
hybridized to the Sentrix HumanHT-12 v3 Expression BeadChips
(Illumina, Inc., San Diego, USA). Each chip contains 12 arrays and
each array contains 448,000 gene transcripts, of which, 46,000
derived from human genes in the National Center for Biotechnol-
ogy Information (NCBI) Reference Sequence (RefSeq) and UniGene
databases. All reagents and equipment used for hybridization
were purchased from Illumina, Inc. According to the manufac-
turer’s protocol, cRNA was hybridized to arrays for 16 h at 58 1C
before being washed and stained with streptavidin-Cy3. Then the
beadchips were centrifuged to dry and scanned on the Illumina
BeadArray Reader confocal scanner. To minimize the batch effect,the microarray chips were all processed at the single site using
the same platform with the identical setting of the parameters by
the same experimenter.
Analysis of differentially expressed genes
The quality of the entire data set was assessed by box plot and
density plot of bead intensities, density plot of coefﬁcient of
variance, pairwise MAplot, pairwise plot with microarray correla-
tion, cluster dendrogram, and non-metric multidimensional scal-
ing using R/Bioconductor and the lumi package (Du et al., 2008).
Based on the quality assessment, all 19 samples were deemed
suitable for further analysis. Data normalization was performed
using a variance-stabilising transform (VST) and a robust spline
normalization (RSN) implemented in the lumi package for
R/Bioconductor (Du et al., 2008; Lin et al., 2008). Cluster analysis
for the whole genome expression of 48,803 transcripts was
performed based on the Pearson correlation metric implemented
in GenomeStudio v2011.1. To reduce false positives, unexpressed
genes (based on a detection p-value cut-off 0.01) were removed
from the dataset. A linear model ﬁt in conjunction with an
empirical Bayes statistics were used to identify candidate DEGs
(Smyth, 2004). P-values were corrected for multiple testing using
FDR adjustment implemented in lumi package. Pair-wise com-
parisons for the four study groups were carried out and candidate
DEGs with fold change 42 and adjusted p o0.05 were identiﬁed
for each of the comparisons.
For the identiﬁed DEGs, KEGG pathway enrichment analysis
from WebGestalt (Web-based Gene SeT AnaLysis Toolkit) was
used to identify the signiﬁcantly enriched pathways (Zhang et al.,
2005). The hypergeometric test was used to calculate the statistic
for each pathway with human genome as the reference gene set
and the p-value was adjusted by Benjamini–Hochberg (BH)
correction. KEGG pathways with adjusted po0.05 and minimum
number of four DEGs being the members of the pathway for the
comparison of INT versus LTNP and minimum number of two
DEGs for the comparison of HVL versus LTNP were identiﬁed as
signiﬁcantly enriched ones.
Gene set enrichment analysis
GSEA was used for both the comparison of our dataset with
published DEG lists from previous studies (in vivo and ex vivo
since 2002) (Cicala et al., 2002; Coberley et al., 2004; Gekonge
et al., 2012; Giri et al., 2009; Tilton et al., 2006; Van den Bergh
et al., 2010; Vazquez et al., 2005; Wen et al., 2005; Woelk et al.,
2004) and the investigation of global dysregulations of the
biological pathways. For the comparison, 10 DEG lists were used
from studies on monocyte/MDM transcriptomes modulated by
HIV (Table 4). For the pathway investigation, the gene sets are
from MsigDB (Subramanian et al., 2005), catalog C2 functional
sets, subcatalog canonical pathways, which include 639 gene
sets from pathway databases (version 2.5). These gene sets are
canonical representations of a biological process compiled by
domain experts such as BioCarta, GenMAPP, and KEGG.
Instead of focusing on discrete DEGs, GSEA analyzed the entire
transcriptome data to identify genes coordinately regulated in pre-
deﬁned gene sets from various biological pathways (Subramanian
et al., 2005). For each group comparison, GSEA was performed using
the normalized data of entire 48,803 transcripts (GSEA version 2.07,
Broad Institute http://www.broad.mit.edu/gsea). First, a ranked list
was obtained by ranking all genes according to the correlation
between their expression and the group distinction using the metric
signal to noise ratio. Then the association between a given gene set
and the group was measured by the non-parametric running sum
statistic termed the enrichment score (ES), which was calculated by
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in the given gene set and decreasing when encountering a gene not in
the gene set. To estimate the statistical signiﬁcance of the ES, a
nominal p value was calculated by permuting the genes 1000 times.
To adjust for multiple hypothesis testing, the maximum ES was
normalized to account for the gene set size (NES) and the false
discovery rate (FDR) corresponding to each NES was calculated. Along
with the pathway enrichment results, the gene set details report for
each signiﬁcant pathway was simultaneously generated, which listed
the details of each gene member with a column indicating whether
this gene was ‘‘core enrichment’’ or not. The core enrichment genes
account for the enrichment signal of the pathway and the inspection
of these genes can reveal a biologically important subset within the
pathway (Subramanian et al., 2005).
Real-time quantitative PCR
Eleven genes and 15 pairs of group comparison were selected
for validation based on the coverage of different levels of fold
change and/or biological signiﬁcance. Puriﬁed total cellular RNA
was reverse transcribed using oligo d(T) and Superscript III
followed by RNase H treatment (Invitrogen Life Technologies).
The cDNA was subjected to qPCR in a 96-well format in triplicate
reactions with deﬁned primers and SYBR Green (Invitrogen Life
Technologies). The qPCR reactions were carried out using
Mx3005PTM QPCR System (Stratagene). The mean expressions of
the tested genes in each group including all the samples used in
the microarray were obtained and the housekeeping gene GAPDH
was used as an internal control and the normalizer for all data.
The fold change was calculated by the relative quantitation
method 2(ddCt). Primer sequences for each transcript are avail-
able from the authors upon request.Conclusions
This study provides the ﬁrst transcriptomic distinctions in
monocytes between HIV viremic patients and long-term non-
progressors, which particularly focuses on the dysregulations of
biological pathways associated with the progression and non-
progression of HIV disease. Between HIVþ groups, the signiﬁcant
down-regulation of the interrelated pathways including TLR
signalling, cytokine–cytokine receptor interaction, cell cycle and
apoptosis, and transendothelial migration is signiﬁcantly asso-
ciated with the more severe disease status, whereas the non-
progression/less advanced disease status is signiﬁcantly asso-
ciated with the up-regulation of these pathways. In the viremic
patients, the global impairment of TLR pathway is exempliﬁed by
the decreased expression of TLR with the subsequent tuning
down of MAPK, NF-kB, JAK-STAT, and IRF signalling cascades in
conjunction. In the cell cycle pathway, the G1/S arrest is newly
identiﬁed along with previously reported G2/M arrest. Focusing
on the global dysregulation of biological pathways, these data
offer new comparative insights into perturbed genetic networks
of ex vivo-derived monocytes subverted by HIV during disease
progression. Further in-depth functional studies on the regulation
of these pathways and the corresponding core enrichment genes
may provide detailed molecular mechanisms underlying HIV-
monocyte interactions during disease progression, which may
aid future therapeutic interventions. Building up a database of
the pathway interactions identiﬁed in monocytes, CD4þ/CD8þ
T cells, B cells, and NK cells will deﬁnitely aid the understanding
of the interconnections between various pathways and diverse
blood leukocytes during HIV infection, which will ultimately
enable the integration of various molecular mechanisms into a
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